Summary
HaCaT cells, a rapidly multiplying human keratinocyte line, were tested for their sensitivity to antipsoriatic dithranol with regard to classical proliferation parameters and for the drug's action on the plasma membrane integrity by the dose- and time-dependent release of cytosolic lactate dehydrogenase (LDH). In the case of 3H thymidine as well as 14C amino acid incorporation the 50% inhibition concentration (IC50) was 0.2 ΜM dithranol 24 h after initial exposure to the drug. For protein content of attached cells the IC50 proved to be>3.0 ΜM. Using 0.3, 1.0 and 3.0 ΜM dithranol, significant (p<0.05) dose dependent LDH release of 0.866±0.387, 1.842±1.127 and 2.938±1.635 mU per hour and cm2 confluent culture area was measured between the 5th and the 24th hour, compared to an acetone control of 0.504±0.299 mU/ h×cm2. Between the 2nd and the 4th hour as well as from the 25th to the 48th hour and the 49th to the 72nd hour the LDH release after dithranol treatment did not exceed the control value. In accordance with these findings dose-dependent morphological signs of cell injury were detected by phase contrast microscopy beyond the 4th hour. The data reveal that: HaCaT cells are a very sensitive target for the antiproliferative action of dithranol; the drug causes considerable plasma membrane damage even at concentrations as low as 0.3 ΜM; and this membrane damage becomes evident after a latency of at least 4 h and for a limited period of up to 24 h.
Similar content being viewed by others
References
Anon (1970) Recommendations of the German society for clinical chemistry — Standardisation of methods for the estimation of enzyme activity in biological fluids. Z Klin Chem Klin Biochem 8:659–660
Ashton RE, Andre P, Lowe NJ, Whitefield M (1983) Anthralin: historical and current perspectives. J Am Acad Dermatol 9:173–192
Bedord CJ, Young JM, Wagner BM (1983) Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro. J Invest Dermatol 81:566–571
Bonnekoh B, Wevers A, Jugert F, Merk H, Mahrle G (1989) Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity. Arch Dermatol Res 281:487–490
Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761–771
Cavey D, Caron JC, Shroot B (1981) Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition. Br J Dermatol 105 [Suppl 20]:15–19
Chopra J, Joist JH, Webster RO (1987) Loss of 51chromium, lactate dehydrogenase, and 111indium as indicators of endothelial cell injury. Lab Invest 57:578–584
Clark JM, Hanawalt PC (1982) Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells. J Invest Dermatol 79:18–22
Condrea E, Lefkowitz I, Jerushalmy Z (1987) Lactate dehydrogenase leakage as indicator of blood platelet lysis by phospholipases A2: possible sources of error. Clin Chim Acta 169:309–314
Courtney JM, Gaylor JDS (1986) Artificial membranes. In: McAinsh TF (ed) Physics in medicine and biology encyclopedia, vol I. Pergamon Press, Oxford, pp 22–26
Duvall E, Wyllie AH (1986) Death and the cell. Immunol Today 7:115–119
Freshney RI (1987) Culture of animal cells, 2nd edn. Alan R Liss, New York
Fuchs J (1988) Validity of the “bioassay” for thioredoxin-reductase activity. Arch Dermatol 124:849–850
Fuchs J, Packer L (1989) Investigations of anthralin free radicals in model systems and in skin of hairless mice. J Invest Dermatol 92:677–682
Fuchs J, Zimmer G, Wölbing RH, Milbradt R (1986) On the interaction between anthralin and mitochondria: a revision. Arch Dermatol Res 279:59–65
Fuchs J, Nitschmann WH, Packer L (1990) The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes. J Invest Dermatol 94:71–76
Klem EB (1978) Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture. J Invest Dermatol 70:27–32
Lotti T, Brunetti L, Panconesi E (1986) A “novel” action of anthralin. Arch Dermatol 122:748–749
Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18:50–60
Mol MAE, Van Genderen J, Wolthuis OL (1986) Cultured human epidermal cells as a tool in skin toxicology. Food Chem Toxicol 24:519–520
Morlière P, Dubertret L, Sa E Melo T, Salet C, Fosse M, Santus R (1985) The effect of anthralin (dithranol) on mitochondria. Br J Dermatol 112:509–515
Müller K, Wiegrebe W, Younes M (1987) Dithranol, active oxygen species and lipid peroxidation in vivo. Arch Pharm (Weinheim) 320:59–66
Prunieras M, Delescluse C (1984) Epidermal cell culture systems in skin pharmacology. Br J Dermatol 27:43–57
Pullmann H, Enderer K, Steigleder GK (1981) Cytokinetic effects of anthralin on psoriatic keratinocytes. Br J Dermatol 105 [Suppl 20]:55–56
Raab W, Patermann F (1966) Die Wirkung externer Antipsoriatika auf die Zellatmung. Arch Klin Exp Dermatol 226:144–152
Rassner G (1971) AktivitÄtshemmung von Enzymen des Kohlenhydratstoffwechsels durch Dithranol. Arch Dermatol Forsch 241:237–244
Reichert U (1986) Skin toxicity and cellular metabolism: in vitro models. Br J Dermatol 115 [Suppl 31]:108–116
Reichert U, Shroot B (1987) Effect of antipsoriatic drugs on the basic metabolism of cultured human keratinocytes. In: Maibach HI, Lowe NJ (eds) Models in dermatology, vol III. Karger, Basel, pp 16–22
Reichert U, Jacques Y, Grangeret M, Schmidt R (1985) Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol 84:130–134
Reichert U, Schmidt R, Shroot B (1985) The mode of action of anthralin: antirespiratory activity and subcellular distribution in cultured human keratinocytes. J Invest Dermatol 84:302
Retzow A, Plumier E, Wiegrebe W (1981) Untersuchungen zur Hemmung der Glucose-6-phosphat-Dehydrogenase durch Dithranol. Pharm Zeitg 126:2150–2155
Schallreuter KU, Pittelkow MR (1987) Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis — a new mode of action for this drug. Arch Dermatol 123:1494–1498
Schallreuter KU, Pittelkow MR, Wood JM (1989): EF-hands calcium binding regulates the thioredoxin reductase/thioredoxin electron transfer in human keratinocytes. Biochem Biophys Res Commun 162:1311–1316
Schiele F (1988) Lactate dehydrogenase. In: Siest G, Galteau MM (eds) Drug effects on laboratory test results. PSG Publishing Company, Littleton, Massachusetts, p 269
Schliwa M, Euteneuer U, Porter KR (1987) Release of enzymes of intermediary metabolism from permeabilized cells: further evidence in support of a structural organization of the cytoplasmic matrix. Eur J Cell Biol 44:210–218
Schröder J-M, Kosfeld U, Christophers E (1985) Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils. J Invest Dermatol 85:30–34
Steigleder GK, Schumann H, Lennartz KJ (1973) Autoradiographic in vitro examination of psoriatic skin before, during and after dithranol treatment. Arch Dermatol Forsch 246:231–235
Stein GH (1979) T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol 99:43–54
Tucker WFG, MacNeil S, Dawson RA, Tomlinson S, Bleehen SS (1986) An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin). J Invest Dermatol 87:232–235
Author information
Authors and Affiliations
Additional information
This study was supported by the “Wilhelm-Doerenkamp-Stiftung”. B. F. is a fellow of the “Alexander-von-Humboldt-Stiftung”
Rights and permissions
About this article
Cite this article
Bonnekoh, B., Farkas, B., Geisel, J. et al. Lactate dehydrogenase release as an indicator of dithranol-induced membrane injury in cultured human keratinocytes. Arch Dermatol Res 282, 325–329 (1990). https://doi.org/10.1007/BF00375727
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00375727